Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: A population-based evaluation

International Journal of Urology

Volumn 20, Issue 11, 2013, Pages 1064-1071

  Bianchi, Marco ^a   Becker, Andreas ^a,b   Abdollah, Firas ^a   Trinh, Quoc Dien ^a,c   Hansen, Jens ^a,b   Tian, Zhe ^a   Shariat, Shahrokh F ^d   Perrotte, Paul ^e   Karakiewicz, Pierre I ^a,e   Sun, Maxine ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Laparoscopic nephrectomy; Open nephrectomy; Partial nephrectomy; Radical nephrectomy; Renal cell carcinoma; Time trends

Indexed keywords

AGED; ARTICLE; COMORBIDITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LAPAROSCOPIC PARTIAL NEPHRECTOMY; LAPAROSCOPIC RADICAL NEPHRECTOMY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OPEN PARTIAL NEPHRECTOMY; OPEN RADICAL NEPHRECTOMY; PARTIAL NEPHRECTOMY; POPULATION DENSITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE; SOCIAL STATUS; SURGICAL TECHNIQUE; TUMOR VOLUME;

LAPAROSCOPIC NEPHRECTOMY; OPEN NEPHRECTOMY; PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; RENAL CELL CARCINOMA; TIME TRENDS;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; LAPAROSCOPY; MALE; MULTIVARIATE ANALYSIS; NEPHRECTOMY; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84886778386     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12110     Document Type: Article

References (33)

1. Doeuk N, Guo DY, Haddad R etal. Renal cell carcinoma: stage, grade and histology migration over the last 15 years in a large Australian surgical series. BJU Int. 2011; 107: 1381-1385.
2. Sun M, Thuret R, Abdollah F etal. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in north america: a trend analysis. Eur. Urol. 2011; 59: 135-141.
3. Baillargeon-Gagné S, Jeldres C, Lughezzani G etal. A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma. BJU Int. 2010; 105: 359-364.
4. Zini L, Patard JJ, Capitanio U etal. The use of partial nephrectomy in European tertiary care centers. Eur. J. Surg. Oncol. 2009; 35: 636-642.
5. Van Poppel H, Da Pozzo L, Albrecht W etal. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur. Urol. 2011; 59: 543-552.
6. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors - is there a difference in mortality and cardiovascular outcomes? J. Urol. 2009; 181: 55-61; discussion 61-2.
7. Thompson RH, Boorjian SA, Lohse CM etal. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J. Urol. 2008; 179: 468-471; discussion 472-3.
8. Weight CJ, Larson BT, Fergany AF etal. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J. Urol. 2010; 183: 1317-1323.
9. Huang WC, Levey AS, Serio AM etal. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006; 7: 735-740.
10. Sun M, Trinh Q-D, Bianchi M etal. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur. Urol. 2012; 61: 725-731.
11. Tan H-J, Norton EC, Ye Z, Hafez KS, Gore JL, Miller DC. Long-term survival following partial vs radical nephrectomy among older patients with early-stage kidney cancer. JAMA 2012; 307: 1629-1635.
12. Stief CG. If a partial nephrectomy could be done safely for a renal tumor, would radical nephrectomy be considered malpractice? Eur. Urol. 2011; 60: 465-466; discussion 6-7.
13. Breau RH, Crispen PL, Jenkins SM, Blute ML, Leibovich BC. Treatment of patients with small renal masses: a survey of the american urological association. J. Urol. 2011; 185: 407-414.
14. Kim SP, Shah ND, Weight CJ etal. Contemporary trends in nephrectomy for renal cell carcinoma in the United States: results from a population based cohort. J. Urol. 2011; 186: 1779-1785.
15. Thompson RH, Kaag M, Vickers A etal. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J. Urol. 2009; 181: 993-997.
16. Miller DC, Taub DA, Dunn RL, Wei JT, Hollenbeck BK. Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J. Urol. 2006; 176: 1102-1106; discussion 1106-7.
17. Miller DC, Wei JT, Dunn RL, Hollenbeck BK. Trends in the diffusion of laparoscopic nephrectomy. JAMA 2006; 295: 2480-2482.
18. Jeong W, Rha KH, Kim HH etal. Comparison of laparoscopic radical nephrectomy and open radical nephrectomy for pathologic stage T1 and T2 renal cell carcinoma with clear cell histologic features: a multi-institutional study. Urology 2011; 77: 819-824.
19. Tan H-J, Wolf JS, Ye Z, Wei JT, Miller DC. Population-level comparative effectiveness of laparoscopic versus open radical nephrectomy for patients with kidney cancer. Cancer 2011; 117: 4184-4193.
20. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med. Care 2002; 40 (8 Suppl): IV-3-20118.
21. Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am. J. Epidemiol. 2011; 174: 860-870.
22. Klabunde C, Potosky A, Legler J, Warren J. Development of a comorbidity index using physician claims data. J. Clin. Epidemiol. 2000; 53: 1258-1267.
23. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitiduinal studies: development and validation. J. Chronic Dis. 1987; 40: 373-383.
24. Du XL, Fang S, Coker AL etal. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 2006; 106: 1276-1285.
25. Zini L, Perrotte P, Capitanio U etal. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer 2009; 115: 1465-1471.
26. Kates M, Badalato GM, Pitman M, McKiernan JM. Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2cm or less. J. Urol. 2011; 186: 1247-1253.
27. Sun M, Abdollah F, Shariat S etal. Propensity-score matched comparison of complications, blood transfusions, length of stay, and in-hospital mortality between open and laparoscopic partial nephrectomy: a national series. Eur. J. Surg. Oncol. 2012; 38: 80-87.
28. Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer 2010; 116: 2316-2321.
29. Sun M, Hansen J, Karakiewicz PI. Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht etal. A Prospective, Randomized EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma. Eur Urol 2011; 59: 543-52. Eur. Urol. 2012; 61: e37-38.
30. Miller D, Saigal C, Banerjee M, Hanley J, Litwin M. Diffusion of surgical innovation among patients with kidney cancer. Cancer 2008; 112: 1708-1717.
31. Sun M, Bianchi M, Trinh Q etal. Hospital volume is a determinant of postoperative complication, blood transfusion, length of stay after radical or partial nephrectomy. J. Urol. 2012; 187: 405-410.
32. Kutikov A, Uzzo R. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J. Urol. 2009; 182: 844-853.
33. Kutikov A, Egleston BL, Wong Y-N, Uzzo RG. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J. Clin. Oncol. 2010; 28: 311-317.